Hi RockStar, in $APRE at an average of 5.09. Just a starter for now. But, I do think the correction down from $26 on a failed phase 3 was a bit much.....looking for a technical bounce soon, and will be interested to see what the conference leads to on Tuesday to see if there is still some value in the p53 for other purposes. I think they are investigating it for multiple diseases and pathologies, which makes this interesting IMO. GLTY and thanks for starting the board.